Cardiology, Diabetes & Nephrology at the Limits Canada 2021
 

Programme


Chairs
Professor Derek Yellon Professor Dan Drucker Dr Mansoor Husain Dr Gary Lewis
University College London, Mount Sinai Hospital, University of Toronto, Banting & Best Diabetes Centre,
UK Toronto, Canada Canada Toronto, Canada
 
Professor Alice Cheng Professor John Cunningham Dr Peter Libby Professor Marc Pfeffer
University of Toronto,
Canada
UCL Medical School &
The Royal Free Hospital, UK
Brigham & Women’s Hospital &
Harvard Medical School, USA
Brigham & Women’s Hospital,
USA
 
Professor Theresa McDonagh Professor Brian Rayner
King’s College London, UK The University of Cape Town, South Africa

Monday, 1 March
8:00 am

Breakfast & Coffee

 

Registration & Badge Collection

   
9:30 am

Welcome to the event

The Chairs

   
 

The Lancet Lecture:
100 years of insulin have we reached the limits?

Professor Bernard Zinman

Lunenfeld-Tanenbaun Research Institute & Mount Sinai Hospital & University of Toronto, Canada

   
 

Controlling cardiovascular risk factors in 2020-beyond glucose.

Professor Lawrence Leiter

St. Michael's Hospital & University of Toronto, Canada

   
 

Break

   
 

Cardiac atheroma at the limits - are we fighting the final battle?

Professor Peter Libby

Brigham and Women's Hospital & Harvard Medical School, Boston, USA

   
 

Industry Satellite Symposium.

   
1:00 pm

Lunch

   
2:00 pm

Primordial cardiology in youth - what are the limits?

Professor John Deanfield

University College London, UK

   
 

The new genetics & therapies of dyslipidemias.

Professor Robert A Hegele

Robarts Research Institute, Ontario, Canada

   
 

Break

   
 

Debate:
Should metformin be first line therapy?

No: Professor Alice Cheng

University of Toronto, Canada


 

Yes: Professor Cliff Bailey

Aston University, UK

   
 

Cardiovascular mechanisms of GLP-1 and its emerging co-agonist partners.

Professor Dan Drucker

University of Toronto, Canada

   
5:30 pm Close & Buffet Dinner
   
Tuesday, 2 March
8:00 am

Breakfast & Coffee

   
9:00 am

Clinical benefit of Modern therapy for type 2 diabetes-GLP-1 analogues.

Professor Mansoor Husain

University of Toronto, Canada

   
 

The science of obesity, where might this lead clinical practice?

Professor Sean Wharton

Toronto East General Hospital, Canada

   
 

Surprising findings from clinical trials - cardiology, diebetes & nephrology.

Professor Marc Pfeffer

Harvard Medical School, Boston, USA

   
 

Break

   
 

SGLT2i Cardiorenal mechanisms in diabetes and beyond.

Professor Julie Lovshin
University of Toronto, Canada

   
 

Industry Satellite Symposium.

   
1:25 pm Lunch
   
2:25 pm

Heart failure therapy - extending the limit!

Professor Teresa McDonagh
Kings College London, UK

   
  Debate:
Would you entrust your heart to a nephrologist or your kidneys to a cardiologist?
 

Professor Philip Kalra (Nephrologist)

University of Manchester, UK

Dr Paul Kalra (Nephrologist)

University of Portsmouth, UK
   
4:05 pm

Close & depart

Support

CDNATL Canada 2021 is financially supported by the Pharmaceutical Industry and Academia. The Pharmaceutical Industry’s financial support for the event is restricted primarily to facilitating the development of the independent medical/scientific content and speaker fees. Funds from the Pharmaceutical Industry have not been used for travel, accommodation or any other ancillary expenses for participants. Supporters have had no input into the content of the independent scientific sessions or any other aspect of the meeting. Supporters are listed here.